Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-03T00:19:53.388Z Has data issue: false hasContentIssue false

14 - Serum markers for gynaecological cancer in the reproductive years

from SECTION 4 - Diagnostic Dilemmas

Published online by Cambridge University Press:  05 October 2014

Ranjit Manchanda
Affiliation:
EGA Institute for Women’s Health
Usha Menon
Affiliation:
EGA Institute for Women’s Health
Sean Kehoe
Affiliation:
John Radcliffe Hospital, Oxford
Eric Jauniaux
Affiliation:
University College Hospital, London
Pierre Martin-Hirsch
Affiliation:
Royal Preston Hospital
Philip Savage
Affiliation:
Charing Cross Hospital, London
Get access

Summary

Introduction

The current trend of increasing life expectancy and advancing age at which women opt to have children suggests that the number of cancers presenting in pregnancy is likely to increase. The recent triennial Confidential Enquiry into Maternal Deaths in the UK reported the deaths of 81 women from cancer in pregnancy during 2003—05, compared with 28 in 2000—02. However, this increase in number was thought to be entirely due to a more intensive follow-up of the ‘late coincidental deaths’ identified through the Office for National Statistics (ONS) linkage system. Nine of these were attributable to gynaecological malignancies: four choriocarcinomas, two ovarian and three vulval or uterine cancers.

Conservative management of gynaecological cancer with fertility preservation is becoming increasingly important in the reproductive age group. This requires early detection and effective monitoring and follow-up. In addition, diagnosis of cancer in pregnancy is complicated by physiological changes, which tend to mask signs and symptoms, together with the limitations of imaging and other investigative modalities. In such a situation, serum tumour markers, despite difficulties in interpretation, play an important role. This chapter focuses on the various tumour markers relevant to gynaecological malignancies in premenopausal women and their role in management.

Tumour markers

Tumour markers are molecules or substances produced by or in response to neoplastic proliferation and which enter the circulation in detectable amounts. They indicate the likely presence of cancer or provide information about its behaviour.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×